Atazanavir signature I50L resistance substitution accounts for unique phenotype of increased susceptibility to other protease inhibitors in a variety of human immunodeficiency virus type 1 genetic backbones
about
X-Ray Crystal Structures of Human Immunodeficiency Virus Type 1 Protease Mutants Complexed with AtazanavirHIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance TestingA multifaceted analysis of HIV-1 protease multidrug resistance phenotypesDistinct functions of NS5A in hepatitis C virus RNA replication uncovered by studies with the NS5A inhibitor BMS-790052Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults.Interaction of I50V mutant and I50L/A71V double mutant HIV-protease with inhibitor TMC114 (darunavir): molecular dynamics simulation and binding free energy studies.Effect of natural polymorphisms in the HIV-1 CRF02_AG protease on protease inhibitor hypersusceptibilityMutations in multiple domains of Gag drive the emergence of in vitro resistance to the phosphonate-containing HIV-1 protease inhibitor GS-8374.Atazanavir: simplicity and convenience in different scenarios.Clinical pharmacology, efficacy and safety of atazanavir: a review.HIV-1 protease mutations and protease inhibitor cross-resistance.Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance
P2860
Q27645052-B0EB7EF8-8C13-4A55-8149-B971BD05C9E7Q28271593-FBCC8E70-1FD4-48E8-AF08-5A707ACFBE69Q34102058-09BC7F84-D2B2-4A7E-B32D-E124A325FA1BQ34185949-6B613D2B-45FD-4F4B-8945-56D8D9FDCDB1Q35079510-7B7AD81D-7D5E-45A5-B22A-0002BAB59F46Q35783809-32381C8E-04CF-47F1-BB1F-BFAD5AFECD9CQ35941273-E1F390E9-8773-432A-8C6C-1BAEA349AE4CQ36506829-F5BCC445-DF0C-47E6-8B1E-D5E733C4610EQ36765802-42F34744-692A-4B39-885F-39F1D8942367Q37622972-09844415-F586-48D2-89C0-82136C7717B4Q42421248-C20D2800-0E40-4AA6-A5A2-CF47868898B3Q42704311-5C74A438-12A2-4577-959E-1D71147D6352
P2860
Atazanavir signature I50L resistance substitution accounts for unique phenotype of increased susceptibility to other protease inhibitors in a variety of human immunodeficiency virus type 1 genetic backbones
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Atazanavir signature I50L resi ...... virus type 1 genetic backbones
@ast
Atazanavir signature I50L resi ...... virus type 1 genetic backbones
@en
type
label
Atazanavir signature I50L resi ...... virus type 1 genetic backbones
@ast
Atazanavir signature I50L resi ...... virus type 1 genetic backbones
@en
prefLabel
Atazanavir signature I50L resi ...... virus type 1 genetic backbones
@ast
Atazanavir signature I50L resi ...... virus type 1 genetic backbones
@en
P2093
P2860
P1476
Atazanavir signature I50L resi ...... virus type 1 genetic backbones
@en
P2093
P2860
P304
P356
10.1128/AAC.49.9.3816-3824.2005
P407
P577
2005-09-01T00:00:00Z